thorax Flashcards
key questions to ask
-Smoking History:
-Previous Cancers
-Personal and Family History of Cancer
-Current Lung Diseases:
-Chronic obstructive pulmonary disease (COPD)
-Emphysema
-Interstitial lung disease
-Travel History:
-Endemic TB Regions
-History of:
-rheumatoid arthritis -> rheumatoid lung
-Granulomatosis with polyangiitis
-Other autoimmune disorders
solitary pulmonary nodule/coin lesion
-Discrete lesion that is rounded and normal lung parenchyma surrounds it
-<3 is cm in diameter
-No associated findings such as:
-Lymphadenopathy
-Atelectasis
-Pneumonia
-When located in a patient > 50 high risk of it being lung cancer.
-General Population Screening: 2 – 24%
-High Risk Population Screening: 17 – 53%
-Vast majority are benign.
-Key to tx is making the correct diagnosis. Why?
-Fear of Malignancy!!!!
physical exam
-not usually helpful
-may help if there are assoc pulmonary diseases -> TB, COPD, emphysema, chronic bronchitis
diagnostic tools
-Computed Tomography (CT):
-Most Likely to Detect solitary pulmonary nodule!!!!
-Best Modality for Follow-up (subtle 1 – 2 mm changes in size)
-picks up small changes in size
-Chest Radiograph:
-Most Commonly! used
-Performed as an Initial Diagnostic Imaging Study
-incidental finding
-compare to previous images
-MRI:
-use if there is a Cystic of Ground-Glass Lesions
-PET Scan:
-use If SPN > 8mm
-likely cancer if larger
-Electromagnetic Navigation Bronchoscopy (ENB):
-$$$ Noninvasive Modality
-not really needed
-Tumor Markers:
-See Next Slide
-**Biopsy!!:
-Ultimately Need Tissue
tumor markers
-Carcinoembryonic Antigen (CEA):
-Colon and rectum(colorectal or bowel cancer)
-Prostate
-Ovary
-Lung
-Thyroid
-Liver
-Pancreas
-Breast
-Folate Receptor-Positive Circulating Tumor Cells:
-Ovarian
-Non-Small Cell Lung Cancer (NSCLC)
-tumor markers are not always present -> not used as screening bc of this
-useful for monitoring of reoccurrence of a tumor that was previously secreting a marker
tumor markers: galectin-3-binding protein
-Breast Cancer
-Lung Cancer
-Melanoma
-Ovarian
-HCC
-Pancreatic Cancer
-Prostate
-Oral Squamous Cell Cancer
-Neuroblastoma
-Glioblastoma Multiforme
-Gastric Cancer
-Lymphoma
-Colon Cancer
-Mesothelioma
-Ewing’s Sarcoma
C163A
-investigation for use in risk stratification for cancer
-shows promise in eval of benign lung lesions
-not yet developed
-expieremental
x ray
-is this a nodule or a nipple shadow
-right lower
x ray
-squamous cell carcinoma -> strip blood supply -> necrosis
-cyst or abscess
-air fluid level
x ray
-nipples
approach to a small pulmonary nodule
-SPN Found on CXR
-Look for prior films to collaborate finding
-If on an old film then interval surveillance is acceptable
-If it is a new lesion, go to CT scan evaluation
-High suspicion on CT Scan, move to PET scan
-PET-avid lesion in a smoker if they are a good candidate resection is suggested
-After PET still unclear or poor surgical candidate perform biopsy
-If biopsy attempt fails, then wedge resection via VATS
complication of SPN intervention
-Usually Attributed to Surgical Interventions:
-Bleeding
-PE
-Infections:
-Empyema
-Pneumonia
-Surgical site infections
-Pleural Effusion
-Pneumothorax
-Myocardial Infarction
-Central neurological events- stroke
lung cancer etiology
-Smoking***
-Passive Smoking
-Treatment of Non-Lung Cancer- Breast, Non-Hodgkins Lymphoma -> Radiation exposure
-Heavy Metal Exposure: Chromium, Nickel, Arsenic, and Polycyclic aromatic hydrocarbons
-Lung Diseases: Idiopathic Pulmonary FIbrosis
-Exposures: Asbestos, Radon
types of lung cancer
-Adenocarcinoma
-Squamous Cell Carcinoma
-Adenosquamous Carcinoma
-Large Cell Carcinoma
-Small Cell Carcinoma
NSCLC
-Adenocarcinoma
-can also be a Squamous Cell Carcinoma (women; central lesion, smokers 1st or 2nd hand)
-Surgical resection, chemotherapy, radiotherapy, and immunotherapy
-Potential Operability & Surgical Cure
SCLC
-Central Necrosis
-Sensitive to CTX but high recurrence rate
-MC with paraneoplastic syndromes
-Surgical Cure is NOT a Realistic Option but is Utilized
-Median Survival 7 Months
-toes, bones, and perio-osteo overgrowth -> hypertrophic pulmonary osteoarthropathy
tumor location
-central- sclc -> metastasize
-peripheral- nsclc
questions to ask
-Smoking History
-Work History
-Exposures
-Nothing specific exists to look for or ask on the history & physical examination
-perineoplastic signs?
hx and PE
-Local Factors
-Compression Factors- SVC syndrome- plethoric face, edema -> radiation immediately (not surgery) -> this is a emergency -> need to restore blood flow
-Paraneoplastic Factors
-Cough 50 – 70% of patients- primary and metastatic pts
clubbing
-not exclusive to lung cancer
concerning presentations
-Cough
-lesion with Pneumonia
-Hemoptysis- can be tb
-Chest Pain
-Dyspnea
-SVC Syndrome
-Metastatic Disease:
-Bone (20% in NSCLC; 30 – 40% in SCLC)
-Brain (20% in SCLC)
-Liver (uncommon until advanced)
serious complications
-SVC Syndrome: Common in SCLC
-Pancoast Syndrome:
-Superior Sulcus Tumor of Wide Mediastinum
-Shoulder Pain
-Horner Syndrome- ptosis, miosis, anhidrosis -> Neurovascular involvement is bad prognosis -> involves stellate ganglion - sympathetic chains C6-C7 (numbness/tingling of hand/arm)
-Bone Erosion- clavicle
-Atrophy of Hand Muscles- innervation abnormalities
-Paraneoplastic Syndromes
-PTH-like Hormone
-SIADH-Like Hormone
-ACTH-Lile Hormone (SCLC)
-Lambert-Eaton Myasthenia Syndrome- myasthenia gravis
flow chart for lung cancer
-important for staging
staging workup for all lung cancer pts
-CT scan of chest and upper abdomen -> metastasize to adrenal glands -> Addisonian crisis!!!
-CBC w/ diff- leukocytosis, anemia
-serum chemistry - Cr, electrolytes, Ca, alk phos - hypercalcemia
-aspartate aminotransferase (AST)
-pulmonary function testing- required only if surgical resection is considered
-mediastinoscopy- required only if surgical resection is considered
molecular testing
-Epidermal growth factor receptor (EGFR) mutation (MC; Peripheral)!!
-Anaplastic lymphoma kinase (ALK) rearrangement (MC, Central)!!!
-use these to tell if its bronchogenic or non-bronchogenic / peripheral or central)
DONT NEED TO KNOW:
-BRAFV600Emutation
-RETrearrangement
-ROS-1rearrangement
-NTRK 1/2/3gene fusion
-METexon 14 skipping
-KRASG12C mutation
-Programmed death ligand 1 (PD-L1) expression
tx recommendation of non small cell lung cancer
-know the stage and management
prognostic factors
-non small cell cancer
-large central lesion
-bronchoscopy
-transbronchial bx